The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Why Do Patients With Atrial Fibrillation Not Receive Warfarin?
Abstract
Atrial fibrillation (AF) is a growing public health problem associated with significant morbidity and mortality. Numerous randomized controlled trials of warfarin have conclusively demonstrated that long-term anticoagulation therapy can reduce the risk for stroke by approximately 68% per year in patients with nonvalvular AF, and even more in patients with valvular AF. However, available data show that of those patients with AF and no contraindication to warfarin therapy, only 15% to 44% are prescribed warfarin. Our literature review has identified patient-, physician-, and health care system-related barriers to warfarin prescription. However, the relative importance of these specific barriers remains unknown. Further work is needed to understand the discrepancy between the randomized controlled trial evidence and clinical practice patterns.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Feinberg, W. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.469 · Cited by 2,274
Petersen, P., Godtfredsen, J., Boysen, G., Andersen, E., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,820
Davis, D. A. (1995) · JAMA · doi:10.1001/jama.1995.03530090032018 · Cited by 1,763
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
Stroke Prevention in Atrial Fibrillation Study. Final results.
(1991) · Circulation · doi:10.1161/01.cir.84.2.527 · Cited by 1,696
(1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232201 · Cited by 1,530
Canadian atrial fibrillation anticoaguiation (CAFA) study
Connolly, S. J., Laupacis, A., Gent, M., Roberts, R. S., Cairns, J. A., & Joyner, C. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90585-w · Cited by 1,111
Atrial Fibrillation: A Major Contributor to Stroke in the Elderly: The Framingham Study
Wolf, P. A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090041008 · Cited by 1,108
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280227 · Cited by 1,067
Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force.
ASINGER, R. W., Dyken, M. L., Fisher, M., Hart, R., & Sherman, D. G. (1989) · PubMed · Cited by 548
Prevalence of atrial fibrillation and eligibility for anticoagulants in the community
Sudlow, M., Thomson, R., Thwaites, B., Rodgers, H., & Kenny, R. A. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01401-9 · Cited by 383
Ezekowitz (1992) · New England Journal of Medicine · Cited by 266
Warfarin Use Among Patients With Atrial Fibrillation
Brass, L. M., Krumholz, H. M., Scinto, J. M., & Radford, M. (1997) · Stroke · doi:10.1161/01.str.28.12.2382 · Cited by 241
Written case simulations: Do they predict physicians' behavior?
Jones, T. V., Gerrity, M. S., & Earp, J. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90241-g · Cited by 233
Physician Attitudes About Anticoagulation for Nonvalvular Atrial Fibrillation in the Elderly
McCrory, D. C. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.3.277 · Cited by 233
Gottlieb, L. K. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420170093009 · Cited by 224
National Patterns of Warfarin Use in Atrial Fibrillation
Stafford, R. S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.22.2537 · Cited by 212
Rethans, J. J., Sturmans, F., Drop, R., van der Vleuten, C., & Hobus, P. (1991) · BMJ · doi:10.1136/bmj.303.6814.1377 · Cited by 201
Lip, G. Y. H., Golding, D. J., Nazir, M., Beevers, D. G., Child, D., & Fletcher, R. (1997) · Europe PMC (PubMed Central) · Cited by 182
Atrial Fibrillation and Stroke Prevention With Warfarin in the Long-term Care Setting
Gurwitz, J. H. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.9.978 · Cited by 169
Treatment of atrial fibrillation in a district general hospital.
Lip, G. Y. H., Tean, K. N., & Dunn, F. G. (1994) · Heart · doi:10.1136/hrt.71.1.92 · Cited by 154
Monette, J., Gurwitz, J. H., Rochon, P. A., & Avorn, J. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb05967.x · Cited by 153
Kutner, M. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400100038006 · Cited by 152
Thomson, R., McElroy, H., & Sudlow, M. (1998) · BMJ · doi:10.1136/bmj.316.7130.509 · Cited by 127
Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation
Antani, M. R., Beyth, R. J., Covinsky, K. E., Anderson, P. A., Miller, D. G., Cebul, R. D., Quinn, L., & Landefeld, C. S. (1996) · Journal of General Internal Medicine · doi:10.1007/bf02598984 · Cited by 121
Warfarin for Atrial Fibrillation: The Patient's Perspective
Man‐Son‐Hing, M., Laupacis, A., O'Connor, A., Wells, G., Lemelin, J., Wood, W., & Dermer, M. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.16.1841 · Cited by 117
Handa, V. L., Landerman, R., Hanlon, J. T., Harris, T. B., & Cohen, H. J. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb05630.x · Cited by 116
Why isn’t warfarin prescribed to patients with nonrheumatic atrial fibrillation?
Beyth, R. J., Antani, M. R., Covinsky, K. E., Miller, D. G., Chren, M., Quinn, L., & Landefeld, C. S. (1996) · Journal of General Internal Medicine · doi:10.1007/bf02598985 · Cited by 114
Thromboembolism Prophylaxis in Chronic Atrial Fibrillation
Munschauer, F. E., Priore, R. L., Hens, M. M., & Castilone, A. (1997) · Stroke · doi:10.1161/01.str.28.1.72 · Cited by 110
Is Warfarin Underused in the Treatment of Elderly Persons With Atrial Fibrillation?
Whittle, J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440250097011 · Cited by 98
Physician Variation in Anticoagulating Patients With Atrial Fibrillation
Chang, H. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.1.83 · Cited by 88
Physician Variation in Anticoagulating Patients With Atrial Fibrillation
Chang, H. J. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390130089012 · Cited by 86
Stroke Prevention in Nonvalvular Atrial Fibrillation
Albers, G. W., Atwood, J. E., Hirsh, J., Sherman, D. G., Hughes, R. A., & Connolly, S. J. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-727 · Cited by 78
Brodsky, M. A. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.22.2553 · Cited by 74
Lightowlers, S., & McGuire, A. J. (1998) · Stroke · doi:10.1161/01.str.29.9.1827 · Cited by 71
How To Do It: Service provision and use of anticoagulants in atrial fibrillation: FIG 1
Sudlow, C. L. M., Rodgers, H., Kenny, R. A., & Thomson, R. G. (1995) · BMJ · doi:10.1136/bmj.311.7004.558 · Cited by 61
Performance on PMPs and performance in practice
Page, G. G., & Fielding, D. W. (1980) · Academic Medicine · doi:10.1097/00001888-198006000-00009 · Cited by 48
Sandvik, H. (1995) · PubMed · Cited by 43
Lawson, F. M. E., McAlister, F. A., Ackman, M. L., Ikuta, R. M., & Montague, T. J. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb01837.x · Cited by 21
Self-citationHoward, P. A., & Duncan, P. W. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703101012 · Cited by 18
Medical Problem-Solving Assessment
Vu, N. V. (1979) · Evaluation & the Health Professions · doi:10.1177/016327877900200302 · Cited by 15
Antithrombotic Therapy Prescribed for Patients with Non-Rheumatic Atrial Fibrillation
Hendry, A., Campbell, A. M., Campbell, G., MACDONALD, J. B., & Williams, B. (1994) · Scottish Medical Journal · doi:10.1177/003693309403900404 · Cited by 13
Cited by
Phillips, L. S., Branch, W. T., Cook, C. B., Doyle, J. P., El-Kebbi, I. M., Gallina, D. L., Miller, C. D., Ziemer, D. C., & Barnes, C. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00012 · Cited by 1,370
Hylek, E. M., Evans-Molina, C., Shea, C., Henault, L. E., & Regan, S. (2007) · Circulation · doi:10.1161/circulationaha.106.653048 · Cited by 1,061
5-Year Outcomes After Left Atrial Appendage Closure
Reddy, V. Y., Doshi, S. K., Kar, S., Gibson, D. N., Price, M. J., Huber, K., Horton, R. P., Buchbinder, M., Neuzil, P., Gordon, N. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.021 · Cited by 1,032
Reddy, V. Y., Sievert, H., Halperin, J., Doshi, S. K., Buchbinder, M., Neuzil, P., Huber, K., Whisenant, B., Kar, S., Swarup, V., et al. (2014) · JAMA · doi:10.1001/jama.2014.15192 · Cited by 1,018
Metadata
- Authors
- Bungard, T. J., Ghali, W. A., Teo, K. K., McAlister, F. A., & Tsuyuki, R. T.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2000-01-10
- Volume
- 160
- Issue
- 1
- Pages
- 41
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2158454439
- Cited by
- 593
- References
- 43
- FWCI
- 17.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.